Literature DB >> 8720139

Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin.

H Yamamoto1, M Hasegawa, T Ono, K Tashima, Y Ihara, E Miyamoto.   

Abstract

We have reported that many sites of tau in fetal brain (fetal-tau) as well as in paired helical filaments (PHF-tau) are phosphorylated. In the present study, we used site-specific antibodies and peptide mapping to examine protein phosphatases involved in dephosphorylation of fetal-tau and PHF-tau. Immunoblot analysis and electrophoretic mobility showed that protein phosphatases 1 and 2A and calcineurin could dephosphorylate fetal-tau and PHF-tau. Phosphoserines 199, 202, 396, and 413 and phosphothreonine 231, numbered according to the longest human tau isoform, were dephosphorylated, as shown by the immunoblot analysis. Phosphoserine 422 was dephosphorylated by protein phosphatase 2A and calcineurin, but not by protein phosphatase 1. Peptide mapping with Achromobacter lyticus protease 1 showed that phosphoserines 199, 202, 235, and 396 and phosphothreonine 231 were dephosphorylated by protein phosphatases. Fetal-tau was more rapidly dephosphorylated by protein phosphatase 2A and calcineurin than PHF-tau. Interestingly, PHF-tau which had not been solubilized with guanidine HCl was little dephosphorylated by protein phosphatases. Thus, PHF-tau in neurofibrillary tangles of Alzheimer's disease brain is likely to be resistant to dephosphorylation by protein phosphatases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8720139     DOI: 10.1093/oxfordjournals.jbchem.a125011

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

Review 1.  Human fetal tau protein isoform: possibilities for Alzheimer's disease treatment.

Authors:  Nataša Jovanov-Milošević; Davor Petrović; Goran Sedmak; Mario Vukšić; Patrick R Hof; Goran Simić
Journal:  Int J Biochem Cell Biol       Date:  2012-05-15       Impact factor: 5.085

Review 2.  Tau in neurodegenerative diseases: tau phosphorylation and assembly.

Authors:  J Avila; M Pérez; F Lim; A Gómez-Ramos; F Hernández; J J Lucas
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  PP2B isolated from human brain preferentially dephosphorylates Ser-262 and Ser-396 of the Alzheimer disease abnormally hyperphosphorylated tau.

Authors:  A Rahman; I Grundke-Iqbal; K Iqbal
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

5.  Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.

Authors:  Elisa A Waxman; Benoit I Giasson
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

6.  Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.

Authors:  Kensuke Yotsumoto; Taro Saito; Akiko Asada; Takayuki Oikawa; Taeko Kimura; Chiyoko Uchida; Koichi Ishiguro; Takafumi Uchida; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

7.  Isomerase Pin1 stimulates dephosphorylation of tau protein at cyclin-dependent kinase (Cdk5)-dependent Alzheimer phosphorylation sites.

Authors:  Taeko Kimura; Koji Tsutsumi; Masato Taoka; Taro Saito; Masami Masuda-Suzukake; Koichi Ishiguro; Florian Plattner; Takafumi Uchida; Toshiaki Isobe; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2013-01-28       Impact factor: 5.157

8.  Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.

Authors:  Isabelle Landrieu; Caroline Smet-Nocca; Laziza Amniai; Justin Vijay Louis; Jean-Michel Wieruszeski; Jozef Goris; Veerle Janssens; Guy Lippens
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 9.  Molecular Mechanisms in the Pathogenesis of Alzheimer's disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation.

Authors:  Masato Hasegawa
Journal:  Biomolecules       Date:  2016-04-28

Review 10.  Prion-Like Propagation Mechanisms in Tauopathies and Traumatic Brain Injury: Challenges and Prospects.

Authors:  Hadeel Alyenbaawi; W Ted Allison; Sue-Ann Mok
Journal:  Biomolecules       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.